The management of hypercalcemia in cancer patients often involves a combination of hydration, bisphosphonates (which inhibit bone resorption), and calcitonin. In severe cases, dialysis may be necessary. Targeting the underlying cancer with appropriate therapies can also help reduce PTHrP levels and manage hypercalcemia.
